MILLEGEN has a total of 22 patent applications. Its first patent ever was published in 2000. It filed its patents most often in EPO (European Patent Office), WIPO (World Intellectual Property Organization) and United States. Its main competitors in its focus markets biotechnology and pharmaceuticals are F1 ONCOLOGY INC, BEIJING BIOHEALTHCARE BIOTECHNOLOGY CO LTD and NEXTERA AS.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 7 | |
#2 | WIPO (World Intellectual Property Organization) | 7 | |
#3 | United States | 5 | |
#4 | France | 2 | |
#5 | Australia | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals |
# | Technology | |
---|---|---|
#1 | Microorganisms | |
#2 | Peptides | |
#3 | Medical preparations | |
#4 | Therapeutic chemical compounds |
# | Name | Total Patents |
---|---|---|
#1 | Bouayadi Khalil | 18 |
#2 | Kharrat Abdelhakim | 11 |
#3 | Mondon Philippe | 11 |
#4 | Cazaux Christophe | 4 |
#5 | Servant Laurence | 4 |
#6 | Brune Patrick | 4 |
#7 | Renaut Laurence | 4 |
#8 | Louat Thierry | 4 |
#9 | Kharrat Hakim | 4 |
#10 | Hoffmann Jean Sebastien | 4 |
Publication | Filing date | Title |
---|---|---|
EP2018430A1 | Method for expressing polypeptides in eukaryotic cells using alternative splicing | |
EP2027265A1 | Highly diversified antibody libraries | |
EP1847604A1 | Intracellular method for selecting a peptide or polypeptide which binds to a bait peptide or polypeptide | |
EP1811031A1 | Method for selecting a peptide or polypeptide which binds to a target molecule | |
FR2849853A1 | New fusion protein for inducing expression of a gene, useful particularly for regulating gene therapy, also in screening for active agents, comprises nucleic acid-binding, expression-activating and membrane-binding domains | |
FR2816319A1 | Use of dna mutagen polymerase for the creation of random mutations |